Medicare Enrolled
Dr. Ramon Rodriguez-Cruz, MD
Neurology · Orlando, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rodriguez-Cruz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodriguez-Cruz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rodriguez-Cruz
Dr. Ramon Rodriguez-Cruz is a neurology specialist in Orlando, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rodriguez-Cruz performed 40,083 Medicare services across 2,191 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rodriguez-Cruz received a total of $973,008 from 61 pharmaceutical and/or device companies across 1894 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rodriguez-Cruz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in FL
$973,008 industry payments
Medicare Practice Summary
Medicare Utilization ↗40,083
Medicare services
Top 2% in FL for neurology
2,191
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,110 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
34,710 | $5 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,460 | $92 | $163 |
| Rimabotulinumtoxinb injection, 100 units An injection of rimabotulinumtoxinb administered in a dose of 100 units. |
1,101 | $9 | $18 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
842 | $60 | $125 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
247 | $98 | $201 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
246 | $25 | $55 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
213 | $136 | $219 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
200 | $327 | $631 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 159 | $58 | $115 |
| New patient office visit, complex (60-74 min) | 146 | $151 | $313 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
102 | $163 | $271 |
| Electronic analysis of implanted neurostimulator Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device. |
86 | $14 | $50 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 81 | $204 | $389 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
70 | $65 | $124 |
| Chemical nerve block for facial paralysis Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face. |
69 | $134 | $248 |
| Brain stimulator programming, additional 15 minutes Electronic analysis and programming of an implanted brain neurostimulator generator by a qualified health professional. This code applies to each additional 15-minute increment beyond the initial service. |
66 | $34 | $70 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
54 | $73 | $145 |
| Brain stimulator programming, first 15 minutes Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes. |
42 | $37 | $79 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
38 | $95 | $195 |
| Chemical nerve block injection, 1-4 muscles An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated. |
37 | $102 | $227 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $123 | $248 |
| Chemical paralysis of salivary glands, bilateral Injection of a chemical agent to paralyze the salivary glands on both sides of the mouth. |
34 | $98 | $188 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $66 | $112 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $70 | $100 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
13 | $26 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$973,008
Total received (2018-2024)
Avg $139,001/year across 7 years
Top 1% in FL for neurology
61
Companies
1,894
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$860,043 (88.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$104,087 (10.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,878 (0.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$157,285
2023
$195,531
2022
$177,129
2021
$89,853
2020
$78,787
2019
$158,471
2018
$115,952
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$154,642
Acorda Therapeutics, Inc
$144,325
Teva Pharmaceuticals USA, Inc.
$129,457
ABBVIE INC.
$77,254
Eisai Inc.
$70,681
Adamas Pharmaceuticals, Inc.
$70,386
AbbVie Inc.
$43,294
Sunovion Pharmaceuticals Inc.
$42,297
AbbVie, Inc.
$41,103
Neurocrine BioSciences, Inc.
$38,160
Amneal Pharmaceuticals LLC
$29,711
Allergan, Inc.
$27,263
MDD US Operations, LLC
$22,869
Kyowa Kirin, Inc.
$16,666
Boston Scientific Corporation
$16,253
MITSUBISHI TANABE PHARMA AMERICA, INC.
$12,072
ACADIA Pharmaceuticals Inc
$9,165
Abbott Laboratories
$6,561
Avion Pharmaceuticals
$6,184
Genentech, Inc.
$4,770
BOSTON SCIENTIFIC CORPORATION
$3,191
Lilly USA, LLC
$751
Allergan Inc.
$416
Amgen Inc.
$410
Biohaven Pharmaceutical Holding Company Ltd.
$377
ARGENX US, INC.
$371
Biogen, Inc.
$357
PFIZER INC.
$336
US WorldMeds, LLC
$329
Saol Therapeutics Inc.
$300
Biohaven Pharmaceuticals, Inc.
$286
Supernus Pharmaceuticals, Inc.
$249
EMD Serono, Inc.
$246
Merz Pharmaceuticals, LLC
$222
GE HEALTHCARE
$204
Otsuka America Pharmaceutical, Inc.
$199
CSL Behring
$178
GE HealthCare
$139
UCB, Inc.
$138
IDORSIA PHARMACEUTICALS US INC
$122
GRT US Holding, Inc.
$117
Grifols USA, LLC
$93
Lundbeck LLC
$88
Currax Pharmaceuticals LLC
$82
Dynasplint Systems Inc.
$76
Neuronetics, Inc.
$68
Corium, LLC
$64
Takeda Pharmaceuticals U.S.A., Inc.
$61
Alnylam Pharmaceuticals Inc.
$55
Novartis Pharmaceuticals Corporation
$53
LivaNova USA, Inc.
$48
Cala Health, Inc.
$45
Vertical Pharmaceuticals, LLC
$37
Genentech USA, Inc.
$28
Alexion Pharmaceuticals, Inc.
$27
Medtronic, Inc.
$25
Merz North America, Inc.
$24
Hoffmann-La Roche Limited
$24
CATALYST PHARMACEUTICALS, INC.
$21
SCILEX PHARMACEUTICALS INC.
$19
REVANCE THERAPEUTICS, INC.
$15
Top 3 companies account for 44.0% of total payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BOTOX · CALA TRIO · COMIRNATY · CONFIRM RX · CONTRAVE · COPAXONE · CREXONT · DAXXIFY · DUOPA · Dhivy · Duopa · Dynasplint · EMGALITY · ETERNA · Evrysdi · FIRDAPSE · GENERAL DBS · GENERAL DBS · GENERAL THERAPIES · GENERAL - DBS · GOCOVRI · Gamunex-C · General - DBS · Gocovri · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · IonicRF Generator · KISUNLA · KYNMOBI · Kcentra · LATUDA · Leqembi · Lioresal Intrathecal (baclofen injection) · MAVENCLAD · MYOBLOC · NEUROSTAR TMS THERAPY · NORTHERA · NOURIANZ · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · Ongentys · PAXLOVID · PERCEPT PC BRAINSENSE · Proclaim IPG · QULIPTA · QUVIVIQ · Qutenza · RADICAVA · RELEXXII · REXULTI · RYTARY · Rystiggo · SKYCLARYS · SPECTRA WAVEWRITER · SPINRAZA · TECFIDERA · TYSABRI · UBRELVY · ULTOMIRIS · VERCISE · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · XEOMIN · Xadago · Xeomin · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in FL.
Equivalent to $2,427 per 100 Medicare services performed
Geographic Context
Neurologists within 10 mi
87
Per 100K population
6.0
County median income
$77,011
Nearest hospital
UNIVERSITY BEHAVIORAL CENTER
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rodriguez-Cruz is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), with speaking/promotional industry engagement in the top 1% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rodriguez-Cruz experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Rodriguez-Cruz performed 34,710 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rodriguez-Cruz receive payments from pharmaceutical companies?
Yes. Dr. Rodriguez-Cruz received a total of $973,008 from 61 companies across 1,894 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodriguez-Cruz's costs compare to other neurologists in Orlando?
Dr. Rodriguez-Cruz's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodriguez-Cruz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Orlando
Browse neurologists in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
By company
Acorda Therapeutics, Inc Payments to Doctors
See all physicians who received payments from Acorda Therapeutics, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology